A Phase 2b, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study of HTX-019 as Treatment for Postoperative Nausea and Vomiting Following Failed Antiemetic Prophylaxis

Project: Research project

Project Details

StatusFinished
Effective start/end date11/16/21 → 12/2/23

Funding

  • Heron Therapeutics ( Award # ): $5,500.00